Immunohistochemical localization of CD31, CD34, and periostin in vocal fold polyps.


Journal

Acta oto-laryngologica
ISSN: 1651-2251
Titre abrégé: Acta Otolaryngol
Pays: England
ID NLM: 0370354

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 9 11 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: ppublish

Résumé

Long-term voice-abuse or sudden vocal fold microvascular disruption can lead to injury and subsequent repair/remodeling of the vocal fold mucosa. Periostin is known to be involved in airway remodeling and in various otolaryngological diseases. In ischemic heart disease, increased CD31 expression has been observed around cardiomyocytes during remodeling, and endothelial proliferation has been reported to occur at these sites. We investigated the expression and the roles of CD31, CD34, and periostin in the formation of vocal fold polyps. Fifty-seven samples of vocal fold polyps were investigate histopathologically and immunohistochemically. Expression of CD31 and CD34 was detected in 41 (71.9%) and 53 (93.0%) samples, respectively, obtained from patients with vocal fold polyp. Expression of periostin was detected in 41 (71.9%) samples obtained from patients with vocal polyps. The vocal polyp samples could be classified into three histological subtypes. Three patterns of CD31 and CD34 expression were observed in the vocal polyp. Four patterns of periostin expression were observed in vocal polyps. An association was observed between the CD31 expression pattern and the histological subtype of vocal fold polyps. In vocal fold polyps, evaluation of vascular endothelial markers may be useful for staging.

Sections du résumé

BACKGROUND UNASSIGNED
Long-term voice-abuse or sudden vocal fold microvascular disruption can lead to injury and subsequent repair/remodeling of the vocal fold mucosa. Periostin is known to be involved in airway remodeling and in various otolaryngological diseases. In ischemic heart disease, increased CD31 expression has been observed around cardiomyocytes during remodeling, and endothelial proliferation has been reported to occur at these sites.
OBJECTIVES UNASSIGNED
We investigated the expression and the roles of CD31, CD34, and periostin in the formation of vocal fold polyps.
MATERIALS AND METHODS UNASSIGNED
Fifty-seven samples of vocal fold polyps were investigate histopathologically and immunohistochemically.
RESULT UNASSIGNED
Expression of CD31 and CD34 was detected in 41 (71.9%) and 53 (93.0%) samples, respectively, obtained from patients with vocal fold polyp. Expression of periostin was detected in 41 (71.9%) samples obtained from patients with vocal polyps. The vocal polyp samples could be classified into three histological subtypes. Three patterns of CD31 and CD34 expression were observed in the vocal polyp. Four patterns of periostin expression were observed in vocal polyps. An association was observed between the CD31 expression pattern and the histological subtype of vocal fold polyps.
CONCLUSION AND SIGNIFICANCE UNASSIGNED
In vocal fold polyps, evaluation of vascular endothelial markers may be useful for staging.

Identifiants

pubmed: 37902571
doi: 10.1080/00016489.2023.2263483
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

806-813

Auteurs

Yutaka Tateda (Y)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.

Teruyuki Sato (T)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.

Ryoukichi Ikeda (R)

Department of Otolaryngology - Head and Neck Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Otolaryngology, Iwate Medical University, Morioka, Japan.

Risako Kakuta (R)

Department of Otolaryngology - Head and Neck Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.

Kenji Izuhara (K)

Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan.

Takenori Ogawa (T)

Department of Otolaryngology - Head and Neck Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Department of Otolaryngology, Gifu University Graduate School of Medicine, Gifu, Japan.

Kazue Ise (K)

Technical Services Division, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Division of Pathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Hiroki Shimada (H)

Division of Pathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Masashi Katoh (M)

Division of Pathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Keigo Murakami (K)

Division of Pathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Kazuhiro Murakami (K)

Division of Pathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Yasuhiro Nakamura (Y)

Division of Pathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Yukio Katori (Y)

Department of Otolaryngology - Head and Neck Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.

Nobuo Ohta (N)

Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH